RxDoctor Payments Data

Jordan Williams, PA

Physician Assistant · Reno, NVNPI 1063988343

Payments from drug & device makers

$798in general payments, 2019–2025

Across 30 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$290
  • Dexcom, Inc.$109
  • Amgen$85
  • Merck$76
  • Sanofi Pasteur Inc.$56
  • Bayer$52
  • plus $130 from 5 others

What the payments were for

  • Food & beverage$798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$798 in reported general payments places this provider in the 60th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$479
Medicare patients
19
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$65,189
OzempicSemaglutide51$58,826
TradjentaLinagliptin33$23,049
EliquisApixaban22$22,778
XareltoRivaroxaban23$18,234
JanuviaSitagliptin Phosphate13$14,728
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$14,406
MounjaroTirzepatide11$13,976
Breo ElliptaFluticasone/Vilanterol13$5,020
Atorvastatin Calcium254$3,637
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$3,398
Albuterol Sulfate HfaAlbuterol Sulfate107$3,211
Wixela InhubFluticasone Propion/Salmeterol19$2,642
Gabapentin112$2,591
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$1,819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$22,77822 claims
MerckJanuvia$76$14,72813 claims
Lilly USA, LLCMounjaro$22$13,97611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →